Hypersensitivity, Immediate clinical trials
The registry lists 62 studies for Hypersensitivity, Immediate across more than 10 countries. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-10.
Status
- Completed
- 46
- Recruiting
- 6
- Status unknown
- 4
- Withdrawn
- 2
- Terminated
- 2
- Not yet recruiting
- 1
Phase
- Phase 2
- 17
- Phase 1
- 15
- Phase 3
- 5
- Early Phase 1
- 1
- Phase 4
- 1
Where
- United States
- 27
- Canada
- 22
- France
- 6
- Germany
- 5
- Australia
- 4
- Italy
- 3
Who runs them
Allergy Therapeutics (16) · National Institute of Allergy and Infectious Diseases (NIAID) (6) · Assistance Publique - Hôpitaux de Paris (3) · Siolta Therapeutics, Inc. (2) · Dr. George Luciuk (2) · Pfizer (2) · University Hospital of North Norway (2) · Ellodi Pharmaceuticals, LP (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 62 — search for more.
- Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral ChallengesRecruitingNCT07038746Phase 11 country
- BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled AsthmaRecruitingNCT05341726Not applicable1 country
- Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic DermatitisRecruitingNCT07316465Not applicable1 country
- Risk-stratified Testing for Safe Removal of Penicillin Allergy LabelsRecruitingNCT06755281Not applicable1 country
- Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating RoomRecruitingNCT05420935Not applicable1 country
- Assessment of Er:YAG Laser for the Control of Hypersensitivity During Tooth Whitening With Hydrogen PeroxideNot yet recruitingNCT06538129Not applicable
- Optimization of the Skin Test Procedure With Iodinated Contrast Products for Certain Patients Suspected of Immediate HypersensitivityRecruitingNCT064982191 country
- A Phase 1 Study of Cizutamig in IgE Mediated DiseasesWithdrawnNCT07408869Phase 11 country
- Tromsø Birch Rust Allergy Study. Allergy to Birch Rust, a Possible Explanation to Seasonal Airway Allergy During Autumn?CompletedNCT043228381 country
- Clinical Determinants and Perioperative Allergic Reactions (CADECAP Study)CompletedNCT039187721 country
- Pathogenesis of Physical Induced Urticarial SyndromesCompletedNCT008879391 country
- Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test ApplicatorsCompletedNCT07400718Not applicable1 country
- Allergic Disease Onset Prevention StudyCompletedNCT05003804Phase 1/23 countries
- Expanded Access Protocol for Patients With Eosinophilic EsophagitisNo longer availableNCT050951161 country
- A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic AsthmaTerminatedNCT06592768Phase 11 country
- Diagnosis and Physiopathology of Insulin AllergyCompletedNCT01407640Not applicable1 country
- Standardised Drug Provocation Testing in Perioperative HypersensitivityCompletedNCT06065137Not applicable1 country
- Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult VolunteersCompletedNCT06963411Phase 11 country
- Effect of Benralizumab in Atopic DermatitisCompletedNCT03563066Phase 21 country
- 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)CompletedNCT05634746Phase 32 countries
- Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral ChallengesCompletedNCT06445374Phase 11 country
- Norwegian Birch Rust Allergy StudyCompletedNCT056618121 country
- Kenota 1 CWS Method Comparison Validation StudyCompletedNCT057026711 country
- The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin ChallengeCompletedNCT04454229Not applicable3 countries
- Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)CompletedNCT03688074Phase 25 countries
- Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring SubjectsCompletedNCT03627767Phase 321 countries
- Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)WithdrawnNCT00109759Phase 11 country
- Asthma Data Innovation Demonstration ProjectCompletedNCT02162576Not applicable1 country
- Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy VaccineCompletedNCT00133146Phase 21 country
- Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick TestCompletedNCT00258635Phase 21 country
- Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of NancyStatus unknownNCT049207211 country
- Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass PollenCompletedNCT00133159Phase 21 country
- Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree PollenCompletedNCT00118612Phase 21 country
- Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT03720470Phase 318 countries
- Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic RhinitisTerminatedNCT00387478Phase 21 country
- A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy TrialCompletedNCT00580606Phase 1/21 country
- The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom ImmunotherapyCompletedNCT025038001 country
- Peanut Epicutaneous Phase II Immunotherapy Clinical TrialCompletedNCT01904604Phase 21 country
- A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise HealthyStatus unknownNCT03819881Phase 11 country
- Interest of Challenge Tests for Diagnosis of Immediate Hypersensitivity Against Iodinated Contrast AgentsCompletedNCT035254961 country
- A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and SpecialistsCompletedNCT029168881 country
- Oral Immunotherapy for Childhood Egg AllergyCompletedNCT00461097Phase 21 country
- Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)CompletedNCT02163122Early Phase 11 country
- Clinical and Immunological Evaluation of Children With AllergiesCompletedNCT001025701 country
- A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut AllergyCompletedNCT01084174Phase 1/21 country
- A Study to Compare the Effects of Different Sized Particles on Cells in the NoseCompletedNCT01257191Phase 11 country
- Comparison Between spIgE and Skin Prick Test of Local and Imported AeroallergensCompletedNCT02561390Not applicable1 country
- Comparison of Difference Histamine Concentration (1, 5 and 10 mg/ml) for Skin Prick Test Positive ControlCompletedNCT02561429Not applicable1 country
- Peanut Allergy Vaccine Study in Healthy and Peanut-allergic AdultsCompletedNCT00850668Phase 11 country
- Safety of Ertapenem in Beta-lactam Allergic Patients.Status unknownNCT01159379Phase 41 country